FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs
Denali Therapeutics’ Avlayah received FDA approval for treating Hunter syndrome, a rare neurological disorder. The biologic medicine uses Denali’s proprietary drug delivery technology to cross the protective blood-brain barrier. The post FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs appeared first on MedCity News.
More in Pivot Health
Why Agentic AI is Useful But Limited & Other Hot Takes on the AI Market
Fawad Butt, CEO of Penguin Ai, gave his candid thoughts on where the healthcare AI market is headed, including how data leakage could be fueling smarter AI models and the limits of agentic AI in enterprise settings. The post Why Agentic AI is Useful But Limited & Other Hot Takes on the AI Market appeared first on MedCity News.
She spent 20 months battling to die under a euthanasia law. Today Spain let her
Claude connects the dots on sleep apnea diagnosis
New York City hospitals drop Palantir as controversial AI firm expands in UK
More from Pivot News
Fact or fiction: Exploring the reality of AI in payments testing
Exploring the expectations and realities of AI in payments testing.
Patch and perish: The hidden risks of incremental payment modernisation
What strategic capabilities must executives invest in now to prevent today’s rising real-time volumes from becoming tomorrow’s systemic or reputational failures?